These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16011728)

  • 1. Eradication of Helicobacter pylori: recent advances in treatment.
    McLoughlin RM; O'Morain CA; O'Connor HJ
    Fundam Clin Pharmacol; 2005 Aug; 19(4):421-7. PubMed ID: 16011728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients.
    Qasim A; Sebastian S; Thornton O; Dobson M; McLoughlin R; Buckley M; O'Connor H; O'Morain C
    Aliment Pharmacol Ther; 2005 Jan; 21(1):91-6. PubMed ID: 15644050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Helicobacter pylori infection.
    O'Connor A; Gisbert J; O'Morain C
    Helicobacter; 2009 Sep; 14 Suppl 1():46-51. PubMed ID: 19712168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Helicobacter pylori.
    Wolle K; Malfertheiner P
    Best Pract Res Clin Gastroenterol; 2007; 21(2):315-24. PubMed ID: 17382279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Rescue' therapies for the management of Helicobacter pylori infection.
    Di Mario F; Cavallaro LG; Scarpignato C
    Dig Dis; 2006; 24(1-2):113-30. PubMed ID: 16699270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures.
    Gisbert JP; Gisbert JL; Marcos S; Moreno-Otero R; Pajares JM
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1469-74. PubMed ID: 17032282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure.
    Ueki N; Miyake K; Kusunoki M; Shindo T; Kawagoe T; Futagami S; Tsukui T; Inagaki H; Sakamoto C
    Helicobacter; 2009 Apr; 14(2):91-9. PubMed ID: 19298336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori eradication therapy.
    Suzuki H; Nishizawa T; Hibi T
    Future Microbiol; 2010 Apr; 5(4):639-48. PubMed ID: 20353303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori "rescue" therapy after failure of two eradication treatments.
    Gisbert JP; Pajares JM
    Helicobacter; 2005 Oct; 10(5):363-72. PubMed ID: 16181345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen.
    Rokkas T; Sechopoulos P; Robotis I; Margantinis G; Pistiolas D
    Am J Gastroenterol; 2009 Jan; 104(1):21-5. PubMed ID: 19098844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy.
    Uygun A; Ozel AM; Yildiz O; Aslan M; Yesilova Z; Erdil A; Bagci S; Gunhan O
    J Gastroenterol Hepatol; 2008 Jan; 23(1):42-5. PubMed ID: 17559359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates.
    Romano M; Iovene MR; Russo MI; Rocco A; Salerno R; Cozzolino D; Pilloni AP; Tufano MA; Vaira D; Nardone G
    J Clin Pathol; 2008 Oct; 61(10):1112-5. PubMed ID: 18755715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori: diagnosis and treatment.
    Selgrad M; Kandulski A; Malfertheiner P
    Curr Opin Gastroenterol; 2009 Nov; 25(6):549-56. PubMed ID: 19696666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Helicobacter pylori.
    Egan BJ; Katicic M; O'Connor HJ; O'Morain CA
    Helicobacter; 2007 Oct; 12 Suppl 1():31-7. PubMed ID: 17727458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to proceed in Helicobacter pylori-positive chronic gastritis refractory to first- and second-line eradication therapy.
    Vaira D; Ricci C; Lanzini A; Perna F; Romano A; Corinaldesi R
    Dig Dis; 2007; 25(3):203-5. PubMed ID: 17827940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Helicobacter pylori infection.
    Cavallaro LG; Egan B; O'Morain C; Di Mario F
    Helicobacter; 2006 Oct; 11 Suppl 1():36-9. PubMed ID: 16925610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Helicobacter pylori infection.
    Egan BJ; Marzio L; O'Connor H; O'Morain C
    Helicobacter; 2008 Oct; 13 Suppl 1():35-40. PubMed ID: 18783520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of rifabutin triple therapy for patients with difficult-to-eradicate Helicobacter pylori in clinical practice.
    Van der Poorten D; Katelaris PH
    Aliment Pharmacol Ther; 2007 Dec; 26(11-12):1537-42. PubMed ID: 17903237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
    Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S
    J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.